학술논문
Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO)
Document Type
article
Author
Anne Quinquenel; Thérèse Aurran-Schleinitz; Aline Clavert; Florence Cymbalista; Caroline Dartigeas; Frédéric Davi; Sophie de Guibert; Alain Delmer; Marie-Sarah Dilhuydy; Pierre Feugier; Luc-Matthieu Fornecker; David Ghez; Romain Guieze; Kamel Laribi; Véronique Leblond; Stéphane Leprêtre; Rémi Letestu; Vincent Lévy; Florence Nguyen-Khac; Anne-Sophie Michallet; Cécile Tomowiak; Olivier Tournilhac; Loïc Ysebaert; Xavier Troussard; on the behalf of the FILO-LLC Group
Source
HemaSphere, Vol 4, Iss 5, p e473 (2020)
Subject
Language
English
ISSN
2572-9241
00000000
00000000
Abstract
Abstract. As a result of significant recent developments, the management of patients with chronic lymphocytic leukemia (CLL) is changing, and new therapeutic options will continue to emerge in the near future. The recommendations of the French Innovative Leukemia Organization (FILO-CLL) group presented here are intended to provide practical recommendations for physicians taking care of CLL patients, taking into account the availability of both biological tests and therapies in daily practice in France at the time of publication. This text details the documented information and guidelines on diagnosis, indications for treatment, infectious complications and therapeutic strategies in frontline and relapsed CLL as well as in particular conditions such as autoimmune cytopenia or Richter syndrome.